septemb
reuter
health
singapor
said
develop
new
sever
acut
respiratori
syndrom
sar
test
kit
capabl
detect
antibodi
respiratori
viru
minut
case
result
known
minut
kit
use
blood
droplet
requir
special
train
presenc
antibodi
sar
viru
signal
patient
infect
sar
said
genelab
diagnost
pte
ltd
develop
kit
singapor
institut
molecular
cell
biolog
kit
avail
hospit
next
month
genelab
said
sold
public
singapor
research
also
develop
sar
test
produc
result
larg
number
sampl
minut
guan
ming
product
develop
manag
genelab
said
test
sampl
sar
patient
use
compar
healthi
peopl
develop
test
kit
test
evalu
china
hong
kong
sar
hit
hard
detect
viru
day
infect
research
hope
develop
test
viru
first
day
editor
comment
interest
day
news
releas
patient
infect
sarsassoci
coronaviru
diagnos
singapor
hospit
diagnosi
confirm
us
center
diseas
control
prevent
see
pro
medmail
archiv
number
septemb
http
www
promedmailorg
patient
case
meet
theworld
health
organ
clinicalepidemiolog
case
definit
sar
infect
mild
pulmonari
infiltr
known
contact
possibl
probabl
case
present
time
work
hypothesi
infect
laboratori
acquir
septemb
reuter
health
call
doctor
citizen
take
precaut
winter
sever
acut
respiratori
syndrom
sar
viru
could
return
china
daili
said
medic
expert
said
sar
origin
south
china
novemb
fade
juli
may
dormant
other
fear
milder
mutat
version
may
still
circul
peopl
take
possibl
measur
prevent
influenza
autumn
winter
may
also
see
return
sar
newspap
said
quot
health
author
quot
author
say
concern
futur
flu
case
respiratori
diseas
could
mistaken
sar
kill
peopl
countri
infect
thousand
hong
kong
scientist
test
anim
sold
delicaci
southern
chines
market
confirm
suspicion
sar
jump
human
anim
research
found
clear
differ
anim
human
strain
viru
said
minor
enough
show
sar
came
anim
influenza
virus
done
world
health
organ
said
august
china
decis
lift
ban
sale
exot
anim
food
prematur
china
ban
sale
anim
may
declar
war
sar
critic
cover
initi
outbreak
mani
speci
wild
anim
kept
sold
butcher
unsanitari
market
southern
china
resid
famous
omnivor
appetit
pay
high
price
eat
delicaci
editor
comment
china
decis
lift
ban
sale
exot
anim
food
also
unfortun
sar
may
persist
human
popul
occasion
mild
case
time
tell
howev
persist
chines
decis
perpetu
exot
cycl
make
reemerg
sar
anim
kingdom
much
like
suspect
sar
relat
speci
jump
furthermor
may
wors
infecti
diseas
sar
wait
emerg
exot
group
mention
editori
comment
follow
preced
articl
case
laboratorydiagnos
sarsassoci
coronaviru
infect
recent
report
singapor
mild
case
known
sar
contact
probabl
acquir
research
laboratori
lack
virul
could
relat
season
lack
coinfect
occur
season
even
infect
strain
loss
virul
laboratori
passag
howev
also
provid
evid
potenti
exist
mild
case
commun
case
would
low
infect
could
conceiv
ii
cid
novemb
news
allow
viru
emerg
human
popul
fall
winter
septemb
reuter
health
megan
rauscher
research
univers
francisco
develop
rapid
specif
highli
sensit
test
identifi
patholog
infecti
prion
protein
isoform
prpsc
respons
bovin
spongiform
encephalopathi
bse
may
appli
live
anim
current
immunoassay
use
detect
prpsc
cattl
inadequ
largescal
screen
detect
prpsc
anim
die
often
produc
falseposit
slow
yield
result
conformationdepend
immunoassay
cdi
repres
new
gener
test
prion
dr
jiri
g
safar
said
telephon
interview
reuter
health
describ
nation
meet
american
chemic
societi
new
york
citi
cdi
base
total
new
principl
accord
dr
safar
old
test
abl
detect
abnorm
prpsc
first
destroy
normal
counterpart
prpc
present
practic
everi
tissu
process
lose
larg
percentag
abnorm
protein
left
littl
detect
explain
cdi
requir
degrad
process
employ
antibodi
abl
specif
distinguish
normal
protein
ubiquit
abnorm
protein
infecti
research
said
field
trial
compar
cdi
exist
immunoassay
cdi
accur
detect
prpsc
brain
slaughter
cow
spain
unit
kingdom
germani
transgen
mice
overexpress
bovin
prion
protein
suscept
bse
cdi
abl
detect
infecti
prion
muscl
tissu
earli
week
prpsc
inocul
use
cdi
san
francisco
investig
also
consist
detect
prpsc
blood
rodent
experiment
infect
prion
concentr
prion
muscl
blood
lower
brain
need
extrem
sensit
test
abl
detect
low
think
dr
safar
told
reuter
health
origin
bse
european
problem
appear
first
bse
case
canada
reach
north
america
worldwid
problem
dr
safar
said
predict
tissu
blood
test
bse
live
anim
could
avail
year
cdi
may
eventu
use
screen
patient
human
form
bse
variant
creutzfeldtjakob
diseas
vcjd
thought
acquir
consumpt
bseinfect
beef
product
cdi
technolog
licens
inpro
biotechnolog
inc
san
francisco
compani
found
dr
safar
coinvestig
dr
stanley
prusin
first
discov
abnorm
prion
protein
caus
diseas
accomplish
nobel
prize
septemb
reuter
health
research
said
tri
new
treatment
west
nile
viru
infect
use
immun
globulin
isra
surviv
infect
passiv
immun
experiment
may
offer
shortterm
protect
peopl
risk
seriou
complic
viru
includ
enceph
brain
inflamm
west
nile
viru
first
report
unit
state
infect
peopl
kill
year
accord
us
center
diseas
control
prevent
west
nile
viru
emerg
problem
unit
state
year
public
health
offici
particularli
concern
diseas
appear
spread
quickli
wide
last
year
nation
institut
allergi
infecti
diseas
niaid
director
dr
anthoni
fauci
said
statement
current
clinician
provid
support
care
patient
infect
west
nile
viru
ad
hope
result
studi
ultim
give
physician
patient
use
treatment
option
west
nile
viru
report
half
centuri
africa
recent
southern
europ
niaidl
research
use
immun
globulin
prepar
blood
serum
isra
volunt
expos
viru
decad
isra
biopharmaceut
compani
omrix
develop
product
research
look
patient
hospit
treat
lifethreateningwest
nile
viru
infect
editor
comment
unclear
news
item
subject
given
immun
globulin
peopl
risk
seriou
complic
viru
elderli
immunocompromis
person
develop
west
nile
viru
infect
plan
give
immun
globulin
alreadi
cn
involv
person
present
fever
ie
treatment
prevent
cn
involv
plan
latter
may
difficult
find
enough
case
patient
control
subject
